# SOLIFENACIN SUCCINATE
> **ANDA209839** · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2019-05-20
## Drug
- **FDA Application Number:** ANDA209839
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SOLIFENACIN SUCCINATE
- **Generic name:** Solifenacin Succinate
- **Active ingredients:** SOLIFENACIN SUCCINATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** CIPLA
- **First approval:** 2019-05-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209839)
---
*AI Analytics · CC0 1.0*